Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing the Reliability of Integrated Consensus Strategies to Boost Docking-Based Screening Campaigns Using Publicly Available Docking Programs.

Molecular informatics·2025
Same author

Assessing the Robustness and Scalability of Machine Learning Methods to Accelerate Ultralarge High-Throughput Docking Campaigns.

ACS omega·2025
Same author

Lessons learnt from machine learning in early stages of drug discovery.

Expert opinion on drug discovery·2024
Same author

The Impact of Supervised Learning Methods in Ultralarge High-Throughput Docking.

Journal of chemical information and modeling·2023
Same author

How good are AlphaFold models for docking-based virtual screening?

iScience·2023
Same author

Machine Learning Toxicity Prediction: Latest Advances by Toxicity End Point.

ACS omega·2023

Related Experiment Video

Updated: Jul 14, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Ligand docking and structure-based virtual screening in drug discovery.

Claudio N Cavasotto1, Andrew J W Orry

  • 1MolSoft LLC, 3366 North Torrey Pines Ct. #300, La Jolla, CA 92037, USA. Claudio.N.Cavasotto@uth.tmc.edu

Current Topics in Medicinal Chemistry
|May 19, 2007
PubMed
Summary

Ligand docking and structure-based virtual screening are crucial for discovering novel drug candidates beyond existing compounds. This tutorial covers current challenges, recent advancements, and applications in drug discovery and optimization.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 14, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Molecular modeling

Background:

  • Ligand-docking methods are increasingly vital in identifying and refining potential drug molecules.
  • These techniques enable exploration beyond known active compounds to uncover novel chemical structures (chemotypes).

Purpose of the Study:

  • To provide a tutorial on ligand docking and structure-based virtual screening.
  • To highlight current challenges and recent advancements in the field.
  • To showcase successful applications of docking-based tools.

Main Methods:

  • Review of ligand docking algorithms and methodologies.
  • Discussion of structure-based virtual screening techniques.
  • Exploration of methods to incorporate protein flexibility.

Main Results:

  • Ligand docking plays a critical role in lead discovery and optimization.
  • Successful applications include hit discovery, lead optimization, and library design.
  • Ongoing research focuses on improving accuracy by accounting for protein flexibility.

Conclusions:

  • Ligand-docking-based approaches are essential for modern drug discovery.
  • Advancements in algorithms and methods are continuously improving virtual screening efficacy.
  • Addressing protein flexibility remains a key area for future development.